What is the false‑negative rate of a urine nucleic‑acid amplification test (NAAT) for Trichomonas vaginalis in men?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

False Negative Rate for Trichomonas Urine NAAT in Males

The false negative rate for urine nucleic acid amplification testing (NAAT) for Trichomonas vaginalis in men is approximately 2.8%, meaning the test has a sensitivity of 97.2% 1.

Test Performance Characteristics

The most robust data comes from a large multicenter prospective study evaluating the Xpert TV assay in 4,791 men, which demonstrated:

  • Sensitivity: 97.2% (false negative rate of 2.8%)
  • Specificity: 99.9% (false positive rate of 0.1%)

This means that for every 100 infected men tested, approximately 3 will receive a false negative result 1.

Clinical Context and Implications

Why NAATs Are Preferred

Current guidelines strongly recommend NAATs over traditional methods for male trichomonas testing 2. This preference exists because:

  • Wet mount microscopy: Only 60% sensitive (40% false negative rate) 3
  • Culture methods: Approximately 70% sensitive (30% false negative rate) 3
  • Point-of-care rapid tests: 62-95% sensitive depending on symptom status 3

Important Caveats

Timing of testing matters: If testing for cure after treatment, wait at least:

  • 3 weeks after completing multi-dose metronidazole
  • 4 weeks after single-dose metronidazole

Testing earlier may detect residual nucleic acid from dead organisms, creating false positives rather than false negatives 4.

Specimen type: The 97.2% sensitivity applies specifically to urine specimens in men. Urethral swabs may have different performance characteristics, though urine is the preferred and most commonly used specimen type 5.

Prevalence Data to Contextualize Risk

Male trichomonas infection rates in STI screening populations range from 4.4% to 6.6% 5, 6, with higher rates in:

  • African American men (6.3% vs 1.8% in White men) 6
  • Older men (mean age 39.9 years vs 27.6 for chlamydia) 5, 6
  • Urban vs suburban settings (4.9% vs 1.6%) 6

Practical Recommendation

Given the 97.2% sensitivity, a negative urine NAAT in a symptomatic male patient should be considered highly reliable. However, if clinical suspicion remains very high (partner with confirmed infection, persistent urethral discharge), consider:

  • Repeat testing after 1-2 weeks
  • Empiric treatment per CDC guidelines (metronidazole 2g single dose or tinidazole 2g single dose) 2
  • Evaluation for alternative diagnoses

The excellent specificity (99.9%) means positive results are highly trustworthy with minimal false positives 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.